GlassScriptPhysician profile
Brian W Wakefield
NPI 1861923666
$2,744.00
in general payments reported to CMS, 2019-2025
12 companies · $1,602 in 2025
The $1,602 reported for 2025 was more than what 93% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $11.93 · 2022: $28.31 · 2023: $230 · 2024: $871 · 2025: $1,602.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,500 · Travel and Lodging: $746 · Food and Beverage: $458.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,500.00 |
| Travel and Lodging | $745.91 |
| Food and Beverage | $457.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,272.67 | 2024-2025 | |
| Glaxosmithkline, LLC. | $92.55 | 2023 | Jemperli |
| Biogen, INC. | $92.31 | 2024 | Zurzuvae |
| Coopersurgical, INC. | $78.48 | 2023-2025 | Paragard T 380a, Paragard T 380a, Endosee |
| Sumitomo Pharma America, INC. | $43.17 | 2024-2025 | Myfembree |
| Abbvie INC. | $28.74 | 2021-2023 | Lo Loestrin Fe, Orilissa |
| Myovant Sciences INC. | $28.31 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $23.99 | 2025 | |
| Aspira Women'S Health INC | $23.23 | 2023 | Ova1 |
| Pacira Pharmaceuticals Incorporated | $21.78 | 2023 | Iovera, Exparel |
| Monaghan Medical Corporation | $20.83 | 2023 | Aerobika |
| Organon LLC | $17.94 | 2023 | Nexplanon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Wakefield listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.